Skip to main content
. 2021 Sep 27;11:19099. doi: 10.1038/s41598-021-98646-w

Table 2.

Comparison between probands found to harbor a disease-causing de novo variant and all other probands (undiagnosed or diagnosed with non de novo variant).

Proband with de novo variant All other probands p value
Number of cases (%) 91 (32.5) 189 (67.5)
Age of proband, mean (SD) years 10.5 (10.7) 8.8 (9.8) 0.136
Adult proband (> 18 years), N (%) 16 (17.6) 28 (14.8) 0.551
Sex, N (%)
Male 46 (50.5) 130 (68.8) 0.003
Female 45 (49.5) 59 (31.2)
Paternal age at birth, mean (SD) years 35.3 (6.5) 33.8 (5.9) 0.076
Maternal age at birth, mean (SD) years 32.6 (5.3) 31.2 (5.3) 0.061
Jewish origin, N (%) 91 (100) 185 (97.9) 0.308
Consanguinity, N (%) 0 11 (5.8) 0.018
ES format, N (%) 0.067
Trio 87 (95.6) 165 (87.3)
Quartet 4 (4.4) 18 (9.5)
Duo 0 6 (3.2)
Cases with VUS, N (%) 13 (14.3) 61 (32.3) 0.001
Multiple-affected family (first degree), N (%) 6 (6.6) 48 (25.4) < 0.001
GDD / ID, N (%) 86 (94.5) 166 (87.8) 0.081
MCA, N (%) 16 (17.6) 48 (25.4) 0.145
Epilepsy, N (%) 50 (54.9) 78 (41.3) 0.031
ASD, N (%) 21 (23.1) 54 (28.6) 0.331
Microcephaly, N (%) 20 (22.0) 57 (30.2) 0.151
Abnormal brain MRI findings, N (%) 26 (28.6) 58 (30.7) 0.717
Premature birth, N (%) 8 (8.8) 35 (18.5) 0.034

Statistically significant values (p < 0.05) are given in bold.

ASD, autism spectrum disorder; ES, exome sequencing; GDD, global developmental delay; ID, intellectual disability; MCA, multiple congenital anomalies; MRI, magnetic resonance imaging; N, number; NDD, neurodevelopmental delay; SD, standard deviation; VUS, variant of uncertain significance.